Datasets:

sarus-tech

/

phee

like 2

Follow

Sarus Technologies 9

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"involving\"]], \"start\": [[23]], \"entity_id\": [\"T9\"]}, \"Treatment\": {\"text\": [[\"etizolam, phenobarbital, promethazine and chlorpromazine\"]], \"start\": [[33]], \"entity_id\": [\"T7\"], \"Drug\": {\"text\": [[\"etizolam\"], [\"phenobarbital\"], [\"promethazine\"], [\"chlorpromazine\"]], \"start\": [[33], [43], [58], [75]], \"entity_id\": [\"T12\", \"T13\", \"T14\", \"T15\"]}}, \"Effect\": {\"text\": [[\"A fatal poisoning\"]], \"start\": [[0]], \"entity_id\": [\"T8\"]}, \"Subject\": {\"text\": [[\"A fatal poisoning case\"]], \"start\": [[0]], \"entity_id\": [\"T10\"]}, \"Severity\": {\"text\": [[\"fatal\"]], \"start\": [[2]], \"entity_id\": [\"T11\"], \"value\": \"Medium\"}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[40]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"gemcitabine\"]], \"start\": [[28]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"gemcitabine\"]], \"start\": [[28]], \"entity_id\": [\"T8\"]}, \"Disorder\": {\"text\": [[\"metastatic pancreatic adenocarcinoma\"]], \"start\": [[92]], \"entity_id\": [\"T9\"]}}, \"Effect\": {\"text\": [[\"hemolytic uremic syndrome\"]], \"start\": [[48]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"patient with metastatic pancreatic adenocarcinoma\"]], \"start\": [[79]], \"entity_id\": [\"T6\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"due\"]], \"start\": [[11]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"Leukopenia\"]], \"start\": [[0]], \"entity_id\": [\"T3\"]}, \"Subject\": {\"text\": [[\"parvovirus B19 in a Crohn's disease patient\"]], \"start\": [[18]], \"entity_id\": [\"T5\"], \"Disorder\": {\"text\": [[\"parvovirus B19\"]], \"start\": [[18]], \"entity_id\": [\"T1\"]}}, \"Treatment\": {\"text\": [[\"azathioprine\"]], \"start\": [[68]], \"entity_id\": [\"T6\"], \"Disorder\": {\"text\": [[\"Crohn's disease\"]], \"start\": [[38]], \"entity_id\": [\"T7\"]}, \"Drug\": {\"text\": [[\"azathioprine\"]], \"start\": [[68]], \"entity_id\": [\"T8\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"due\"]], \"start\": [[35]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"Fixed drug eruption of the scrotum\"]], \"start\": [[0]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"methylphenidate\"]], \"start\": [[42]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"methylphenidate\"]], \"start\": [[42]], \"entity_id\": [\"T6\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[11]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"Cytarabine\"]], \"start\": [[0]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"Cytarabine\"]], \"start\": [[0]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"cerebellar syndrome\"]], \"start\": [[19]], \"entity_id\": [\"T5\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[29]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"a case\"]], \"start\": [[10]], \"entity_id\": [\"T3\"]}, \"Effect\": {\"text\": [[\"glaucoma\"]], \"start\": [[20]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"doxetaxel therapy for metastatic breast cancer\"]], \"start\": [[40]], \"entity_id\": [\"T6\"], \"Drug\": {\"text\": [[\"doxetaxel\"]], \"start\": [[40]], \"entity_id\": [\"T9\"]}, \"Disorder\": {\"text\": [[\"metastatic breast cancer\"]], \"start\": [[62]], \"entity_id\": [\"T7\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E2", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E2\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced and enhanced\"]], \"start\": [[14]], \"entity_id\": [\"T9\"]}, \"Treatment\": {\"text\": [[\"L-dopa\"]], \"start\": [[38]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"L-dopa\"]], \"start\": [[38]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"developing into generalized seizures\", \"Myoclonus\"]], \"start\": [[46, 0]], \"entity_id\": [\"T8\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"developed\"]], \"start\": [[145]], \"entity_id\": [\"T11\"]}, \"Treatment\": {\"text\": [[\"CAP with concomitant radiation (XRT)\"]], \"start\": [[41]], \"entity_id\": [\"T9\"], \"Disorder\": {\"text\": [[\"pancreatic cancer\"]], \"start\": [[82]], \"entity_id\": [\"T10\"]}, \"Drug\": {\"text\": [[\"CAP\"]], \"start\": [[41]], \"entity_id\": [\"T14\"]}, \"Route\": {\"text\": [[\"concomitant radiation\"]], \"start\": [[50]], \"entity_id\": [\"T15\"]}}, \"Subject\": {\"text\": [[\"two patients\"]], \"start\": [[132]], \"entity_id\": [\"T8\"], \"Population\": {\"text\": [[\"two\"]], \"start\": [[132]], \"entity_id\": [\"T13\"]}}, \"Effect\": {\"text\": [[\"peripheral neuropathy\"]], \"start\": [[190]], \"entity_id\": [\"T12\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Potential_therapeutic_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Potential_therapeutic_event\", \"Trigger\": {\"text\": [[\"treatment\"]], \"start\": [[90]], \"entity_id\": [\"T10\"]}, \"Subject\": {\"text\": [[\"fibrosis, leading the patient\"]], \"start\": [[39]], \"entity_id\": [\"T9\"]}, \"Treatment\": {\"text\": [[\"peginterferon alfa-2a, ribavirin and boceprevir\"]], \"start\": [[105]], \"entity_id\": [\"T11\"], \"Disorder\": {\"text\": [[\"fibrosis\"]], \"start\": [[39]], \"entity_id\": [\"T8\"]}, \"Drug\": {\"text\": [[\"peginterferon alfa-2a\"], [\"ribavirin\"], [\"boceprevir\"]], \"start\": [[105], [128], [142]], \"entity_id\": [\"T12\", \"T13\", \"T14\"]}, \"Combination\": [{\"event_id\": \"E2\", \"event_type\": \"Combination\", \"Trigger\": {\"text\": [[\"and\"]], \"start\": [[138]], \"entity_id\": [\"T15\"]}, \"Drug\": {\"text\": [[\"ribavirin\"], [\"boceprevir\"], [\"peginterferon alfa-2a\"]], \"start\": [[128], [142], [105]], \"entity_id\": [\"T13\", \"T14\", \"T12\"]}}]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"adverse effects\"]], \"start\": [[30]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"CAP\"]], \"start\": [[49]], \"entity_id\": [\"T6\"], \"Drug\": {\"text\": [[\"CAP\"]], \"start\": [[49]], \"entity_id\": [\"T8\"]}}, \"Effect\": {\"text\": [[\"neurotoxicity\"]], \"start\": [[121]], \"entity_id\": [\"T7\"]}, \"Speculated\": {\"text\": [[\"potential\"]], \"start\": [[20]], \"entity_id\": [\"T9\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"over-anticoagulation\"]], \"start\": [[33]], \"entity_id\": [\"T7\"]}, \"Effect\": {\"text\": [[\"protracted diarrhea\"]], \"start\": [[91]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"warfarin\"]], \"start\": [[127]], \"entity_id\": [\"T6\"], \"Drug\": {\"text\": [[\"warfarin\"]], \"start\": [[127]], \"entity_id\": [\"T8\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Potential_therapeutic_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Potential_therapeutic_event\", \"Trigger\": {\"text\": [[\"for\"]], \"start\": [[19]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"oral therapies\"]], \"start\": [[4]], \"entity_id\": [\"T3\"], \"Disorder\": {\"text\": [[\"type 2 diabetes mellitus\"]], \"start\": [[23]], \"entity_id\": [\"T4\"]}, \"Route\": {\"text\": [[\"oral\"]], \"start\": [[4]], \"entity_id\": [\"T7\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"developed\"]], \"start\": [[53]], \"entity_id\": [\"T10\"]}, \"Treatment\": {\"text\": [[\"the use of nitrofurantoin\"]], \"start\": [[92]], \"entity_id\": [\"T8\"], \"Drug\": {\"text\": [[\"nitrofurantoin\"]], \"start\": [[103]], \"entity_id\": [\"T12\"]}}, \"Subject\": {\"text\": [[\"two patients\"]], \"start\": [[36]], \"entity_id\": [\"T7\"], \"Population\": {\"text\": [[\"two\"]], \"start\": [[36]], \"entity_id\": [\"T11\"]}}, \"Effect\": {\"text\": [[\"lung disease\", \"with histological features of bronchiolitis obliterans organising pneumonia (BOOP)\"]], \"start\": [[63, 118]], \"entity_id\": [\"T9\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"developed\"]], \"start\": [[95]], \"entity_id\": [\"T8\"]}, \"Subject\": {\"text\": [[\"A 57-year-old woman with right bundle branch block +LPH and ventricular premature contractions\"]], \"start\": [[0]], \"entity_id\": [\"T7\"], \"Age\": {\"text\": [[\"57-year-old\"]], \"start\": [[2]], \"entity_id\": [\"T11\"]}, \"Gender\": {\"text\": [[\"woman\"]], \"start\": [[14]], \"entity_id\": [\"T12\"]}, \"Disorder\": {\"text\": [[\"right bundle branch block +LPH\"], [\"ventricular premature contractions\"]], \"start\": [[25], [60]], \"entity_id\": [\"T13\", \"T14\"]}}, \"Effect\": {\"text\": [[\"complete heart block (CHB)\"]], \"start\": [[105]], \"entity_id\": [\"T9\"]}, \"Treatment\": {\"text\": [[\"disopyramide phosphate (Norpace)\"]], \"start\": [[160]], \"entity_id\": [\"T10\"], \"Drug\": {\"text\": [[\"disopyramide phosphate\"]], \"start\": [[160]], \"entity_id\": [\"T15\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"developed\"]], \"start\": [[74]], \"entity_id\": [\"T4\"]}, \"Subject\": {\"text\": [[\"two women, aged 25 and 45\"]], \"start\": [[47]], \"entity_id\": [\"T3\"], \"Population\": {\"text\": [[\"two\"]], \"start\": [[47]], \"entity_id\": [\"T8\"]}, \"Gender\": {\"text\": [[\"women\"]], \"start\": [[51]], \"entity_id\": [\"T9\"]}, \"Age\": {\"text\": [[\"aged 25 and 45\"]], \"start\": [[58]], \"entity_id\": [\"T10\"]}}, \"Effect\": {\"text\": [[\"acute myopia\"]], \"start\": [[84]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"topiramate\"]], \"start\": [[112]], \"entity_id\": [\"T6\"], \"Drug\": {\"text\": [[\"topiramate\"]], \"start\": [[112]], \"entity_id\": [\"T11\"]}, \"Disorder\": {\"text\": [[\"epilepsy\"]], \"start\": [[127]], \"entity_id\": [\"T12\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E2", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E2\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"related\"]], \"start\": [[59]], \"entity_id\": [\"T6\"]}, \"Effect\": {\"text\": [[\"subacute\", \"neurotoxicity\"]], \"start\": [[37, 67]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"methotrexate\"]], \"start\": [[46]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"methotrexate\"]], \"start\": [[46]], \"entity_id\": [\"T3\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"after\"]], \"start\": [[214]], \"entity_id\": [\"T8\"]}, \"Subject\": {\"text\": [[\"a patient\"]], \"start\": [[164]], \"entity_id\": [\"T6\"]}, \"Effect\": {\"text\": [[\"ARDS\", \"severe pulmonary symptoms\"]], \"start\": [[0, 183]], \"entity_id\": [\"T7\"]}, \"Treatment\": {\"text\": [[\"infusion\"], [\"rituximab\"]], \"start\": [[220], [137]], \"entity_id\": [\"T9\", \"T10\"], \"Route\": {\"text\": [[\"infusion\"]], \"start\": [[220]], \"entity_id\": [\"T13\"]}, \"Drug\": {\"text\": [[\"rituximab\"]], \"start\": [[137]], \"entity_id\": [\"T11\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"occurred\"]], \"start\": [[43]], \"entity_id\": [\"T5\"]}, \"Effect\": {\"text\": [[\"acute leukemia\"]], \"start\": [[28]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"Treosulfan\"]], \"start\": [[93]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"Treosulfan\"]], \"start\": [[93]], \"entity_id\": [\"T10\"]}, \"Disorder\": {\"text\": [[\"ovarian cancer\"]], \"start\": [[108]], \"entity_id\": [\"T11\"]}}, \"Subject\": {\"text\": [[\"Seven of the eight cases\"]], \"start\": [[0]], \"entity_id\": [\"T6\"], \"Population\": {\"text\": [[\"eight\"]], \"start\": [[13]], \"entity_id\": [\"T7\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"associated\"]], \"start\": [[12]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"Desipramine\"]], \"start\": [[0]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"Desipramine\"]], \"start\": [[0]], \"entity_id\": [\"T9\"]}}, \"Effect\": {\"text\": [[\"SIADH\"]], \"start\": [[23]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"an elderly woman\"]], \"start\": [[32]], \"entity_id\": [\"T6\"], \"Age\": {\"text\": [[\"elderly\"]], \"start\": [[35]], \"entity_id\": [\"T7\"]}, \"Gender\": {\"text\": [[\"woman\"]], \"start\": [[43]], \"entity_id\": [\"T8\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"precipitate\"]], \"start\": [[13]], \"entity_id\": [\"T4\"]}, \"Subject\": {\"text\": [[\"patients with Cushing's syndrome?\"]], \"start\": [[41]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"propofol\"]], \"start\": [[4]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"propofol\"]], \"start\": [[4]], \"entity_id\": [\"T8\"]}, \"Disorder\": {\"text\": [[\"Cushing's syndrome\"]], \"start\": [[55]], \"entity_id\": [\"T10\"]}}, \"Effect\": {\"text\": [[\"pancreatitis\"]], \"start\": [[25]], \"entity_id\": [\"T6\"]}, \"Speculated\": {\"text\": [[\"Can\"]], \"start\": [[0]], \"entity_id\": [\"T9\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"to\"]], \"start\": [[50]], \"entity_id\": [\"T9\"]}, \"Effect\": {\"text\": [[\"anaphylaxis\"]], \"start\": [[38]], \"entity_id\": [\"T7\"]}, \"Treatment\": {\"text\": [[\"5-FU\", \"angiotensin converting enzyme inhibitors\"]], \"start\": [[61, 105]], \"entity_id\": [\"T8\"], \"Drug\": {\"text\": [[\"5-FU\"], [\"angiotensin converting enzyme inhibitors\"]], \"start\": [[61], [105]], \"entity_id\": [\"T10\", \"T11\"]}, \"Combination\": [{\"event_id\": \"E2\", \"event_type\": \"Combination\", \"Trigger\": {\"text\": [[\"interaction\"]], \"start\": [[88]], \"entity_id\": [\"T12\"]}, \"Drug\": {\"text\": [[\"angiotensin converting enzyme inhibitors\"], [\"5-FU\"]], \"start\": [[105], [61]], \"entity_id\": [\"T11\", \"T10\"]}}]}, \"Speculated\": {\"text\": [[\"possibility\"]], \"start\": [[23]], \"entity_id\": [\"T13\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Potential_therapeutic_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Potential_therapeutic_event\", \"Trigger\": {\"text\": [[\"stopping\"]], \"start\": [[6]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"indapamide, glucose tolerance impairing\"]], \"start\": [[15]], \"entity_id\": [\"T5\"], \"Disorder\": {\"text\": [[\"glucose tolerance impairing\"]], \"start\": [[27]], \"entity_id\": [\"T3\"]}, \"Drug\": {\"text\": [[\"indapamide\"]], \"start\": [[15]], \"entity_id\": [\"T9\"]}}, \"Speculated\": {\"text\": [[\"may\"]], \"start\": [[55]], \"entity_id\": [\"T7\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"after\"]], \"start\": [[87]], \"entity_id\": [\"T7\"]}, \"Effect\": {\"text\": [[\"needle-track cutaneous seeding of hepatocellular carcinoma\"]], \"start\": [[22]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"sonographically guided percutaneous ethanol injection\"]], \"start\": [[93]], \"entity_id\": [\"T8\"], \"Route\": {\"text\": [[\"injection\"]], \"start\": [[137]], \"entity_id\": [\"T9\"]}, \"Drug\": {\"text\": [[\"ethanol\"]], \"start\": [[129]], \"entity_id\": [\"T10\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"occurrence\"]], \"start\": [[59]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"Zidovudine\"]], \"start\": [[0]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"Zidovudine\"]], \"start\": [[0]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"birth defects\"]], \"start\": [[73]], \"entity_id\": [\"T5\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"developed\"]], \"start\": [[49]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"A patient with seropositive rheumatoid arthritis\"]], \"start\": [[0]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"ascites\"]], \"start\": [[59]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"taking weekly doses of methotrexate (MTX)\"]], \"start\": [[73]], \"entity_id\": [\"T7\"], \"Disorder\": {\"text\": [[\"seropositive rheumatoid arthritis\"]], \"start\": [[15]], \"entity_id\": [\"T8\"]}, \"Freq\": {\"text\": [[\"weekly\"]], \"start\": [[80]], \"entity_id\": [\"T9\"]}, \"Drug\": {\"text\": [[\"methotrexate\"]], \"start\": [[96]], \"entity_id\": [\"T10\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"receiving\"]], \"start\": [[55]], \"entity_id\": [\"T7\"]}, \"Treatment\": {\"text\": [[\"rifampicin and adjusted doses of lopinavir/ritonavir tablets\"]], \"start\": [[65]], \"entity_id\": [\"T8\"], \"Drug\": {\"text\": [[\"rifampicin\"], [\"lopinavir\"], [\"ritonavir\"]], \"start\": [[65], [98], [108]], \"entity_id\": [\"T11\", \"T13\", \"T14\"]}, \"Route\": {\"text\": [[\"tablets\"]], \"start\": [[118]], \"entity_id\": [\"T12\"]}, \"Dosage\": {\"text\": [[\"adjusted doses\"]], \"start\": [[80]], \"entity_id\": [\"T16\"]}, \"Combination\": [{\"event_id\": \"E2\", \"event_type\": \"Combination\", \"Trigger\": {\"text\": [[\"and\"]], \"start\": [[76]], \"entity_id\": [\"T15\"]}, \"Drug\": {\"text\": [[\"rifampicin\"], [\"lopinavir\"], [\"ritonavir\"]], \"start\": [[65], [98], [108]], \"entity_id\": [\"T11\", \"T13\", \"T14\"]}}]}, \"Subject\": {\"text\": [[\"healthy volunteers\"]], \"start\": [[36]], \"entity_id\": [\"T9\"]}, \"Effect\": {\"text\": [[\"High incidence of adverse events\"]], \"start\": [[0]], \"entity_id\": [\"T10\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"administration\"]], \"start\": [[35]], \"entity_id\": [\"T6\"]}, \"Subject\": {\"text\": [[\"a case\"]], \"start\": [[15]], \"entity_id\": [\"T3\"]}, \"Effect\": {\"text\": [[\"TEN\"]], \"start\": [[25]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"ciprofloxacin\"]], \"start\": [[53]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"ciprofloxacin\"]], \"start\": [[53]], \"entity_id\": [\"T7\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[11]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"Zidovudine\"]], \"start\": [[0]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"Zidovudine\"]], \"start\": [[0]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"pure red cell aplasia\"]], \"start\": [[19]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"a case\"]], \"start\": [[42]], \"entity_id\": [\"T7\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[29]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"gemcitabine\"]], \"start\": [[40]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"gemcitabine\"]], \"start\": [[40]], \"entity_id\": [\"T7\"]}}, \"Effect\": {\"text\": [[\"recall pneumonitis\"]], \"start\": [[10]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"A case\"]], \"start\": [[0]], \"entity_id\": [\"T6\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[10]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"Albuterol\"]], \"start\": [[0]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"Albuterol\"]], \"start\": [[0]], \"entity_id\": [\"T8\"]}}, \"Effect\": {\"text\": [[\"hypokalemia and its potential cardiac toxicity\"]], \"start\": [[18]], \"entity_id\": [\"T7\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Potential_therapeutic_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Potential_therapeutic_event\", \"Trigger\": {\"text\": [[\"treatment\"]], \"start\": [[179]], \"entity_id\": [\"T8\"]}, \"Treatment\": {\"text\": [[\"monthly FU with low-dose LV\"]], \"start\": [[64]], \"entity_id\": [\"T10\"], \"Disorder\": {\"text\": [[\"advanced colorectal cancer\"]], \"start\": [[192]], \"entity_id\": [\"T9\"]}, \"Freq\": {\"text\": [[\"monthly\"]], \"start\": [[64]], \"entity_id\": [\"T11\"]}, \"Drug\": {\"text\": [[\"FU\"], [\"LV\"]], \"start\": [[72], [89]], \"entity_id\": [\"T12\", \"T14\"]}, \"Dosage\": {\"text\": [[\"low-dose\"]], \"start\": [[80]], \"entity_id\": [\"T15\"]}, \"Combination\": [{\"event_id\": \"E2\", \"event_type\": \"Combination\", \"Trigger\": {\"text\": [[\"with\"]], \"start\": [[75]], \"entity_id\": [\"T13\"]}, \"Drug\": {\"text\": [[\"FU\"], [\"LV\"]], \"start\": [[72], [89]], \"entity_id\": [\"T12\", \"T14\"]}}]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"treated\"]], \"start\": [[78]], \"entity_id\": [\"T5\"]}, \"Effect\": {\"text\": [[\"fulminant liver failure\"]], \"start\": [[42]], \"entity_id\": [\"T3\"]}, \"Subject\": {\"text\": [[\"a patient\"]], \"start\": [[21]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"clarithromycin\"]], \"start\": [[91]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"clarithromycin\"]], \"start\": [[91]], \"entity_id\": [\"T7\"]}, \"Disorder\": {\"text\": [[\"pneumonia\"]], \"start\": [[110]], \"entity_id\": [\"T8\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"seen\"]], \"start\": [[119]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"propranolol\"]], \"start\": [[55]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"propranolol\"]], \"start\": [[55]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"2/1 S-A block\"]], \"start\": [[101]], \"entity_id\": [\"T4\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"a probable relationship\"]], \"start\": [[40]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"apnea\"]], \"start\": [[72]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"lamotrigine through breast-feeding\"]], \"start\": [[94]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"lamotrigine\"]], \"start\": [[94]], \"entity_id\": [\"T8\"]}, \"Route\": {\"text\": [[\"breast-feeding\"]], \"start\": [[114]], \"entity_id\": [\"T10\"]}}, \"Subject\": {\"text\": [[\"in this infant\"]], \"start\": [[129]], \"entity_id\": [\"T6\"], \"Age\": {\"text\": [[\"infant\"]], \"start\": [[137]], \"entity_id\": [\"T7\"]}}, \"Speculated\": {\"text\": [[\"probable\"]], \"start\": [[42]], \"entity_id\": [\"T9\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"after\"]], \"start\": [[68]], \"entity_id\": [\"T7\"]}, \"Treatment\": {\"text\": [[\"temozolomide\"]], \"start\": [[74]], \"entity_id\": [\"T8\"], \"Drug\": {\"text\": [[\"temozolomide\"]], \"start\": [[74]], \"entity_id\": [\"T10\"]}}, \"Effect\": {\"text\": [[\"Listeria brain abscess, Pneumocystis pneumonia and Kaposi's sarcoma\"]], \"start\": [[0]], \"entity_id\": [\"T9\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[82]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"amiodarone\"]], \"start\": [[71]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"amiodarone\"], [\"amiodarone\"]], \"start\": [[71], [6]], \"entity_id\": [\"T8\", \"T9\"]}}, \"Effect\": {\"text\": [[\"thyrotoxicosis (AIT)\"]], \"start\": [[90]], \"entity_id\": [\"T7\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"after\"]], \"start\": [[54]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"chemotherapy containing etoposide\"]], \"start\": [[60]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"etoposide\"]], \"start\": [[84]], \"entity_id\": [\"T8\"]}}, \"Effect\": {\"text\": [[\"myocardial infarction\"]], \"start\": [[20]], \"entity_id\": [\"T4\"]}, \"Subject\": {\"text\": [[\"a man with no risk factors for coronary heart disease\"]], \"start\": [[98]], \"entity_id\": [\"T5\"], \"Gender\": {\"text\": [[\"man\"]], \"start\": [[100]], \"entity_id\": [\"T7\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E2", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E2\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"development\"]], \"start\": [[67]], \"entity_id\": [\"T7\"]}, \"Treatment\": {\"text\": [[\"beclomethasone diproprionate inhaler\"]], \"start\": [[11]], \"entity_id\": [\"T4\"], \"Route\": {\"text\": [[\"inhaler\"]], \"start\": [[40]], \"entity_id\": [\"T5\"]}, \"Drug\": {\"text\": [[\"beclomethasone diproprionate\"]], \"start\": [[11]], \"entity_id\": [\"T8\"]}}, \"Effect\": {\"text\": [[\"eosinophilic pneumonia reaction\"]], \"start\": [[85]], \"entity_id\": [\"T6\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"after\"]], \"start\": [[59]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"griseofulvin\"]], \"start\": [[65]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"griseofulvin\"]], \"start\": [[65]], \"entity_id\": [\"T8\"]}}, \"Effect\": {\"text\": [[\"Nephrotic syndrome related to systemic lupus erythematosus\"]], \"start\": [[0]], \"entity_id\": [\"T7\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"mechanisms\"]], \"start\": [[38]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"methanol\"]], \"start\": [[52]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"methanol\"]], \"start\": [[52]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"poisoning\"]], \"start\": [[61]], \"entity_id\": [\"T4\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[25]], \"entity_id\": [\"T10\"]}, \"Subject\": {\"text\": [[\"a case of\", \"a 71-year-old man\", \"for pericardial effusion\"]], \"start\": [[10, 88, 181]], \"entity_id\": [\"T9\"], \"Age\": {\"text\": [[\"71-year-old\"]], \"start\": [[90]], \"entity_id\": [\"T13\"]}, \"Gender\": {\"text\": [[\"man\"]], \"start\": [[102]], \"entity_id\": [\"T14\"]}}, \"Effect\": {\"text\": [[\"Kaposi's sarcoma (KS)\"]], \"start\": [[33]], \"entity_id\": [\"T11\"]}, \"Treatment\": {\"text\": [[\"6 months with corticosteroid therapy (prednisolone 25 mg/day)\"]], \"start\": [[119]], \"entity_id\": [\"T12\"], \"Duration\": {\"text\": [[\"6 months\"]], \"start\": [[119]], \"entity_id\": [\"T16\"]}, \"Dosage\": {\"text\": [[\"25 mg/day\"]], \"start\": [[170]], \"entity_id\": [\"T17\"]}, \"Drug\": {\"text\": [[\"prednisolone\"]], \"start\": [[157]], \"entity_id\": [\"T19\"]}, \"Disorder\": {\"text\": [[\"pericardial effusion\"]], \"start\": [[185]], \"entity_id\": [\"T20\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"toxicity\"]], \"start\": [[39]], \"entity_id\": [\"T7\"]}, \"Subject\": {\"text\": [[\"a young boy with combined variable immunodeficiency syndrome\"]], \"start\": [[90]], \"entity_id\": [\"T6\"], \"Age\": {\"text\": [[\"young\"]], \"start\": [[92]], \"entity_id\": [\"T10\"]}, \"Gender\": {\"text\": [[\"boy\"]], \"start\": [[98]], \"entity_id\": [\"T11\"]}}, \"Treatment\": {\"text\": [[\"acute epinephrine\", \"intravenous immunoglobulin, and was subsequently given epinephrine by mistake intravenously rather than subcutaneously\"]], \"start\": [[21, 193]], \"entity_id\": [\"T8\"], \"Drug\": {\"text\": [[\"epinephrine\"], [\"immunoglobulin\"]], \"start\": [[27], [205]], \"entity_id\": [\"T13\", \"T19\"]}, \"Disorder\": {\"text\": [[\"combined variable immunodeficiency syndrome\"]], \"start\": [[107]], \"entity_id\": [\"T15\"]}, \"Route\": {\"text\": [[\"intravenously\"], [\"intravenous\"]], \"start\": [[271], [193]], \"entity_id\": [\"T16\", \"T18\"]}}, \"Effect\": {\"text\": [[\"acute myocardial ischemia\", \"severe allergic reaction\"]], \"start\": [[61, 165]], \"entity_id\": [\"T9\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"associated\"]], \"start\": [[49]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"lithium\"]], \"start\": [[41]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"lithium\"]], \"start\": [[41]], \"entity_id\": [\"T8\"]}}, \"Effect\": {\"text\": [[\"thyroid dysfunctions\"]], \"start\": [[60]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"Hong Kong Chinese\"]], \"start\": [[120]], \"entity_id\": [\"T6\"], \"Race\": {\"text\": [[\"Hong Kong Chinese\"]], \"start\": [[120]], \"entity_id\": [\"T7\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"associated\"]], \"start\": [[34]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"serotonin syndrome\"]], \"start\": [[50]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"Metaxalone\"]], \"start\": [[0]], \"entity_id\": [\"T6\"], \"Drug\": {\"text\": [[\"Metaxalone\"]], \"start\": [[0]], \"entity_id\": [\"T8\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"related\"]], \"start\": [[15]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"osteonecrosis of the jaw (BRONJ)\"]], \"start\": [[23]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"18.6% of patients\"]], \"start\": [[77]], \"entity_id\": [\"T6\"], \"Population\": {\"text\": [[\"18.6%\"]], \"start\": [[77]], \"entity_id\": [\"T3\"]}}, \"Treatment\": {\"text\": [[\"intravenous bisphosphonates\"]], \"start\": [[108]], \"entity_id\": [\"T7\"], \"Drug\": {\"text\": [[\"Bisphosphonate\"], [\"bisphosphonates\"]], \"start\": [[0], [120]], \"entity_id\": [\"T8\", \"T10\"]}, \"Route\": {\"text\": [[\"intravenous\"]], \"start\": [[108]], \"entity_id\": [\"T9\"]}}, \"Severity\": {\"text\": [[\"significant\"]], \"start\": [[154]], \"entity_id\": [\"T11\"], \"value\": \"High\"}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Potential_therapeutic_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Potential_therapeutic_event\", \"Trigger\": {\"text\": [[\"in\"]], \"start\": [[31]], \"entity_id\": [\"T6\"]}, \"Effect\": {\"text\": [[\"Growth and adrenal suppression\"]], \"start\": [[0]], \"entity_id\": [\"T3\"]}, \"Subject\": {\"text\": [[\"asthmatic children\"]], \"start\": [[34]], \"entity_id\": [\"T4\"], \"Age\": {\"text\": [[\"children\"]], \"start\": [[44]], \"entity_id\": [\"T8\"]}}, \"Treatment\": {\"text\": [[\"high-dose fluticasone propionate\"]], \"start\": [[66]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"fluticasone propionate\"]], \"start\": [[76]], \"entity_id\": [\"T9\"]}, \"Dosage\": {\"text\": [[\"high-dose\"]], \"start\": [[66]], \"entity_id\": [\"T10\"]}, \"Disorder\": {\"text\": [[\"asthmatic\"]], \"start\": [[34]], \"entity_id\": [\"T11\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[26]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"infliximab\"]], \"start\": [[15]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"infliximab\"]], \"start\": [[15]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"lupus\"]], \"start\": [[34]], \"entity_id\": [\"T5\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Potential_therapeutic_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Potential_therapeutic_event\", \"Trigger\": {\"text\": [[\"potential oral\"]], \"start\": [[112]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"rosiglitazone\"]], \"start\": [[95]], \"entity_id\": [\"T7\"], \"Drug\": {\"text\": [[\"rosiglitazone\"]], \"start\": [[95]], \"entity_id\": [\"T10\"]}, \"Disorder\": {\"text\": [[\"type 2 diabetes-mellitus.\"]], \"start\": [[167]], \"entity_id\": [\"T11\"]}, \"Route\": {\"text\": [[\"oral\"]], \"start\": [[122]], \"entity_id\": [\"T12\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"occur\"]], \"start\": [[18]], \"entity_id\": [\"T7\"]}, \"Effect\": {\"text\": [[\"Neurotoxicity\"]], \"start\": [[0]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"high-dose cytosine\"]], \"start\": [[42]], \"entity_id\": [\"T6\"], \"Dosage\": {\"text\": [[\"high-dose\"]], \"start\": [[42]], \"entity_id\": [\"T9\"]}, \"Drug\": {\"text\": [[\"cytosine\"]], \"start\": [[52]], \"entity_id\": [\"T10\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"receiving\"]], \"start\": [[91]], \"entity_id\": [\"T11\"]}, \"Effect\": {\"text\": [[\"phenytoin hypersensitivity\", \"fever, rash, and lymphadenopathy\"]], \"start\": [[19, 147]], \"entity_id\": [\"T10\"]}, \"Treatment\": {\"text\": [[\"phenytoin\"]], \"start\": [[101]], \"entity_id\": [\"T12\"], \"Drug\": {\"text\": [[\"phenytoin\"]], \"start\": [[101]], \"entity_id\": [\"T14\"]}}, \"Speculated\": {\"text\": [[\"possibility\"]], \"start\": [[4]], \"entity_id\": [\"T13\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"cause\"]], \"start\": [[27]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"Magnesium tocolysis\"]], \"start\": [[0]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"Magnesium\"]], \"start\": [[0]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"urinary calculus during pregnancy\"]], \"start\": [[36]], \"entity_id\": [\"T5\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"toxicity\"]], \"start\": [[18]], \"entity_id\": [\"T6\"]}, \"Effect\": {\"text\": [[\"toxicity\"]], \"start\": [[18]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"Ocular ethambutol\"]], \"start\": [[0]], \"entity_id\": [\"T4\"], \"Route\": {\"text\": [[\"Ocular\"]], \"start\": [[0]], \"entity_id\": [\"T7\"]}, \"Drug\": {\"text\": [[\"ethambutol\"]], \"start\": [[7]], \"entity_id\": [\"T8\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"after\"]], \"start\": [[48]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"Fatal intravascular autoimmune hemolytic anemia\"]], \"start\": [[0]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"fludarabine treatment\"]], \"start\": [[54]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"fludarabine\"]], \"start\": [[54]], \"entity_id\": [\"T7\"]}, \"Disorder\": {\"text\": [[\"chronic lymphocytic leukemia\"]], \"start\": [[80]], \"entity_id\": [\"T8\"]}}, \"Severity\": {\"text\": [[\"Fatal\"]], \"start\": [[0]], \"entity_id\": [\"T9\"], \"value\": \"High\"}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"after\"]], \"start\": [[116]], \"entity_id\": [\"T6\"]}, \"Subject\": {\"text\": [[\"A 74-year-old patient with idiopathic Parkinson's disease\"]], \"start\": [[0]], \"entity_id\": [\"T3\"], \"Age\": {\"text\": [[\"74-year-old\"]], \"start\": [[2]], \"entity_id\": [\"T7\"]}}, \"Treatment\": {\"text\": [[\"long-term treatment with 400 mg/day of L-dopa\"]], \"start\": [[122]], \"entity_id\": [\"T4\"], \"Disorder\": {\"text\": [[\"idiopathic Parkinson's disease\"]], \"start\": [[27]], \"entity_id\": [\"T8\"]}, \"Dosage\": {\"text\": [[\"400 mg/day\"]], \"start\": [[147]], \"entity_id\": [\"T9\"]}, \"Drug\": {\"text\": [[\"L-dopa\"]], \"start\": [[161]], \"entity_id\": [\"T10\"]}, \"Duration\": {\"text\": [[\"long-term treatment\"]], \"start\": [[122]], \"entity_id\": [\"T11\"]}}, \"Effect\": {\"text\": [[\"unintended sleep episodes\"]], \"start\": [[76]], \"entity_id\": [\"T5\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"developed\"]], \"start\": [[42]], \"entity_id\": [\"T10\"]}, \"Effect\": {\"text\": [[\"Thrombotic thrombocytopenic purpura (TTP)\"]], \"start\": [[0]], \"entity_id\": [\"T9\"]}, \"Subject\": {\"text\": [[\"a patient with seropositive rheumatoid arthritis (RA)\"]], \"start\": [[55]], \"entity_id\": [\"T11\"]}, \"Treatment\": {\"text\": [[\"2 1/2 months of treatment with penicillamine\"]], \"start\": [[115]], \"entity_id\": [\"T12\"], \"Disorder\": {\"text\": [[\"rheumatoid arthritis\"]], \"start\": [[83]], \"entity_id\": [\"T13\"]}, \"Drug\": {\"text\": [[\"penicillamine\"]], \"start\": [[146]], \"entity_id\": [\"T14\"]}, \"Duration\": {\"text\": [[\"2 1/2 months\"]], \"start\": [[115]], \"entity_id\": [\"T1\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[16]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"Phenolphthalein\"]], \"start\": [[0]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"Phenolphthalein\"]], \"start\": [[0]], \"entity_id\": [\"T7\"]}}, \"Effect\": {\"text\": [[\"toxic epidermal necrolysis\"]], \"start\": [[24]], \"entity_id\": [\"T6\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[37]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"ethylenediamine\"]], \"start\": [[21]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"ethylenediamine\"]], \"start\": [[21]], \"entity_id\": [\"T11\"]}}, \"Effect\": {\"text\": [[\"delayed hypersensitivity reaction\"]], \"start\": [[45]], \"entity_id\": [\"T6\"]}, \"Subject\": {\"text\": [[\"a 46-year-old woman\"]], \"start\": [[82]], \"entity_id\": [\"T7\"], \"Age\": {\"text\": [[\"46-year-old\"]], \"start\": [[84]], \"entity_id\": [\"T9\"]}, \"Gender\": {\"text\": [[\"woman\"]], \"start\": [[96]], \"entity_id\": [\"T10\"]}}}" }, { "event_id": "E2", "event_type": "Potential_therapeutic_event", "event_data": "{\"event_id\": \"E2\", \"event_type\": \"Potential_therapeutic_event\", \"Trigger\": {\"text\": [[\"received\"]], \"start\": [[106]], \"entity_id\": [\"T13\"]}, \"Subject\": {\"text\": [[\"a 46-year-old woman\"]], \"start\": [[82]], \"entity_id\": [\"T7\"], \"Age\": {\"text\": [[\"46-year-old\"]], \"start\": [[84]], \"entity_id\": [\"T9\"]}, \"Gender\": {\"text\": [[\"woman\"]], \"start\": [[96]], \"entity_id\": [\"T10\"]}}, \"Treatment\": {\"text\": [[\"parenteral aminophylline\"]], \"start\": [[115]], \"entity_id\": [\"T14\"], \"Disorder\": {\"text\": [[\"acute asthma exacerbation\"]], \"start\": [[147]], \"entity_id\": [\"T8\"]}, \"Route\": {\"text\": [[\"parenteral\"]], \"start\": [[115]], \"entity_id\": [\"T15\"]}, \"Drug\": {\"text\": [[\"aminophylline\"]], \"start\": [[126]], \"entity_id\": [\"T16\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"of\"]], \"start\": [[66]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"dapsone\"]], \"start\": [[69]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"dapsone\"]], \"start\": [[69]], \"entity_id\": [\"T8\"]}}, \"Effect\": {\"text\": [[\"lethal side effects\"]], \"start\": [[46]], \"entity_id\": [\"T5\"]}, \"Speculated\": {\"text\": [[\"potentially\"]], \"start\": [[34]], \"entity_id\": [\"T6\"], \"value\": true}, \"Severity\": {\"text\": [[\"lethal\"]], \"start\": [[46]], \"entity_id\": [\"T7\"], \"value\": \"High\"}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"during\"]], \"start\": [[26]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"Acute myocardial necrosis\"]], \"start\": [[0]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"amsacrine\"]], \"start\": [[51]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"amsacrine\"]], \"start\": [[51]], \"entity_id\": [\"T6\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"linked\"]], \"start\": [[36]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"speech loss\"]], \"start\": [[24]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"FK506\"]], \"start\": [[46]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"FK506\"]], \"start\": [[46]], \"entity_id\": [\"T7\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"following\"]], \"start\": [[25]], \"entity_id\": [\"T5\"]}, \"Effect\": {\"text\": [[\"pulmonary fibrosis\"]], \"start\": [[6]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy\"]], \"start\": [[35]], \"entity_id\": [\"T6\"], \"Drug\": {\"text\": [[\"1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)\"]], \"start\": [[35]], \"entity_id\": [\"T7\"]}}, \"Severity\": {\"text\": [[\"Fatal\"]], \"start\": [[0]], \"entity_id\": [\"T8\"], \"value\": \"High\"}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"related\"]], \"start\": [[157]], \"entity_id\": [\"T5\"]}, \"Effect\": {\"text\": [[\"associated ulcers\", \"keratitis\"]], \"start\": [[75, 165]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"methamphetamine abuse\", \"methamphetamine\"]], \"start\": [[29, 141]], \"entity_id\": [\"T7\"], \"Drug\": {\"text\": [[\"methamphetamine\"], [\"methamphetamine\"]], \"start\": [[29], [141]], \"entity_id\": [\"T9\", \"T10\"]}}, \"Severity\": {\"text\": [[\"severity\"]], \"start\": [[59]], \"entity_id\": [\"T8\"], \"value\": \"Medium\"}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"diagnosed\"]], \"start\": [[8]], \"entity_id\": [\"T5\"]}, \"Effect\": {\"text\": [[\"MDS\"]], \"start\": [[0]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"8.4 months after beginning TMZ\"]], \"start\": [[18]], \"entity_id\": [\"T6\"], \"Drug\": {\"text\": [[\"TMZ\"]], \"start\": [[45]], \"entity_id\": [\"T7\"]}, \"Time_elapsed\": {\"text\": [[\"8.4 months\"]], \"start\": [[18]], \"entity_id\": [\"T8\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"associated\"]], \"start\": [[8]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"Uveitis\"]], \"start\": [[0]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"rifabutin therapy\"]], \"start\": [[24]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"rifabutin\"]], \"start\": [[24]], \"entity_id\": [\"T6\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[49]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"ciprofloxacin\"]], \"start\": [[35]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"ciprofloxacin\"]], \"start\": [[35]], \"entity_id\": [\"T10\"]}}, \"Effect\": {\"text\": [[\"SJS\"], [\"acute onset of VBDS\"]], \"start\": [[57], [65]], \"entity_id\": [\"T7\", \"T8\"]}, \"Subject\": {\"text\": [[\"a patient\"]], \"start\": [[20]], \"entity_id\": [\"T9\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"trigger\"]], \"start\": [[110]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"cresol\"]], \"start\": [[88]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"cresol\"]], \"start\": [[88]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"MH\"]], \"start\": [[118]], \"entity_id\": [\"T4\"]}, \"Speculated\": {\"text\": [[\"possibly\"]], \"start\": [[101]], \"entity_id\": [\"T7\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"adverse reaction\"]], \"start\": [[42]], \"entity_id\": [\"T5\"]}, \"Effect\": {\"text\": [[\"Neonatal mydriasis\"]], \"start\": [[0]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"lidocaine\"]], \"start\": [[32]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"lidocaine\"]], \"start\": [[32]], \"entity_id\": [\"T6\"]}}, \"Subject\": {\"text\": [[\"Neonatal\"]], \"start\": [[0]], \"entity_id\": [\"T7\"], \"Age\": {\"text\": [[\"Neonatal\"]], \"start\": [[0]], \"entity_id\": [\"T8\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"in\"]], \"start\": [[20]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"Acute renal failure\"]], \"start\": [[0]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"a patient\"]], \"start\": [[23]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"continuous povidone-iodine mediastinal irrigation\"]], \"start\": [[44]], \"entity_id\": [\"T7\"], \"Drug\": {\"text\": [[\"povidone\"], [\"iodine\"]], \"start\": [[55], [64]], \"entity_id\": [\"T8\", \"T9\"]}, \"Route\": {\"text\": [[\"irrigation\"]], \"start\": [[83]], \"entity_id\": [\"T10\"]}, \"Combination\": [{\"event_id\": \"E2\", \"event_type\": \"Combination\", \"Trigger\": {\"text\": [[\"-\"]], \"start\": [[63]], \"entity_id\": [\"T11\"]}, \"Drug\": {\"text\": [[\"povidone\"], [\"iodine\"]], \"start\": [[55], [64]], \"entity_id\": [\"T8\", \"T9\"]}}]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"exacerbated\"]], \"start\": [[57]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"griseofulvin\"]], \"start\": [[44]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"griseofulvin\"]], \"start\": [[44]], \"entity_id\": [\"T9\"]}}, \"Effect\": {\"text\": [[\"lupus\", \"nephrotic syndrome\"]], \"start\": [[69, 84]], \"entity_id\": [\"T7\"]}, \"Subject\": {\"text\": [[\"the first case\"]], \"start\": [[26]], \"entity_id\": [\"T10\"]}, \"Speculated\": {\"text\": [[\"To our knowledge\"]], \"start\": [[0]], \"entity_id\": [\"T8\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"complication\"]], \"start\": [[56]], \"entity_id\": [\"T9\"]}, \"Effect\": {\"text\": [[\"CPM\", \"lithium toxicity\", \"blindness\"]], \"start\": [[46, 72, 150]], \"entity_id\": [\"T8\"]}, \"Treatment\": {\"text\": [[\"lithium\"]], \"start\": [[72]], \"entity_id\": [\"T10\"], \"Drug\": {\"text\": [[\"lithium\"]], \"start\": [[72]], \"entity_id\": [\"T11\"]}}, \"Speculated\": {\"text\": [[\"suggest\"]], \"start\": [[34]], \"entity_id\": [\"T7\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"reaction\"]], \"start\": [[64]], \"entity_id\": [\"T6\"]}, \"Subject\": {\"text\": [[\"A 71-year-old man\"]], \"start\": [[0]], \"entity_id\": [\"T3\"], \"Age\": {\"text\": [[\"71-year-old\"]], \"start\": [[2]], \"entity_id\": [\"T7\"]}, \"Gender\": {\"text\": [[\"man\"]], \"start\": [[14]], \"entity_id\": [\"T8\"]}}, \"Treatment\": {\"text\": [[\"sulfonamide\"]], \"start\": [[78]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"sulfonamide\"], [\"sulfacetamide sodium\"]], \"start\": [[78], [148]], \"entity_id\": [\"T9\", \"T10\"]}}, \"Effect\": {\"text\": [[\"bullous\"]], \"start\": [[51]], \"entity_id\": [\"T5\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"undergoing\"]], \"start\": [[116]], \"entity_id\": [\"T4\"]}, \"Subject\": {\"text\": [[\"two patients\"]], \"start\": [[22]], \"entity_id\": [\"T3\"], \"Population\": {\"text\": [[\"two\"]], \"start\": [[22]], \"entity_id\": [\"T7\"]}}, \"Treatment\": {\"text\": [[\"oral colchicine therapy\"]], \"start\": [[127]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"colchicine\"]], \"start\": [[132]], \"entity_id\": [\"T8\"]}, \"Route\": {\"text\": [[\"oral\"]], \"start\": [[127]], \"entity_id\": [\"T9\"]}}, \"Effect\": {\"text\": [[\"corneal ulcers\"]], \"start\": [[40]], \"entity_id\": [\"T6\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[11]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"Vancomycin\"]], \"start\": [[0]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"Vancomycin\"]], \"start\": [[0]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"vasculitis\"]], \"start\": [[19]], \"entity_id\": [\"T5\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"cause\"]], \"start\": [[63]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"cisplatin\"]], \"start\": [[49]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"cisplatin\"]], \"start\": [[49]], \"entity_id\": [\"T7\"]}}, \"Effect\": {\"text\": [[\"C. difficile colitis\"]], \"start\": [[69]], \"entity_id\": [\"T5\"]}, \"Speculated\": {\"text\": [[\"may\"]], \"start\": [[59]], \"entity_id\": [\"T6\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"associated\"]], \"start\": [[19]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"Nephrotic syndrome\"]], \"start\": [[0]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"lithium therapy\"]], \"start\": [[35]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"lithium\"]], \"start\": [[35]], \"entity_id\": [\"T6\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"developed\"]], \"start\": [[25]], \"entity_id\": [\"T4\"]}, \"Subject\": {\"text\": [[\"2 patients\"]], \"start\": [[10]], \"entity_id\": [\"T3\"], \"Population\": {\"text\": [[\"2\"]], \"start\": [[10]], \"entity_id\": [\"T7\"]}}, \"Effect\": {\"text\": [[\"polyarteritis nodosa\"]], \"start\": [[35]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"vaccination against hepatitis B\"]], \"start\": [[66]], \"entity_id\": [\"T6\"], \"Drug\": {\"text\": [[\"vaccination against hepatitis B\"]], \"start\": [[66]], \"entity_id\": [\"T8\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"where\"]], \"start\": [[81]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"ketorolac\"]], \"start\": [[33]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"ketorolac\"]], \"start\": [[33]], \"entity_id\": [\"T9\"]}}, \"Subject\": {\"text\": [[\"patients with underlying illnesses\"]], \"start\": [[46]], \"entity_id\": [\"T4\"], \"Disorder\": {\"text\": [[\"underlying illnesses\"]], \"start\": [[60]], \"entity_id\": [\"T7\"]}}, \"Effect\": {\"text\": [[\"NSAID-induced ototoxicity could result in adverse otologic consequences\"]], \"start\": [[87]], \"entity_id\": [\"T5\"]}, \"Speculated\": {\"text\": [[\"could\"]], \"start\": [[113]], \"entity_id\": [\"T8\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"associated\"]], \"start\": [[41]], \"entity_id\": [\"T8\"]}, \"Effect\": {\"text\": [[\"Colitis\"]], \"start\": [[0]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"infliximab\"]], \"start\": [[30]], \"entity_id\": [\"T7\"], \"Drug\": {\"text\": [[\"infliximab\"]], \"start\": [[30]], \"entity_id\": [\"T9\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Potential_therapeutic_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Potential_therapeutic_event\", \"Trigger\": {\"text\": [[\"treated\"]], \"start\": [[46]], \"entity_id\": [\"T7\"]}, \"Subject\": {\"text\": [[\"A 15-month-old girl with rhinopharyngitis\"]], \"start\": [[0]], \"entity_id\": [\"T6\"], \"Age\": {\"text\": [[\"15-month-old\"]], \"start\": [[2]], \"entity_id\": [\"T9\"]}, \"Gender\": {\"text\": [[\"girl\"]], \"start\": [[15]], \"entity_id\": [\"T10\"]}}, \"Treatment\": {\"text\": [[\"a nasal solution containing the imidazoline derivative naphazoline\"]], \"start\": [[59]], \"entity_id\": [\"T8\"], \"Disorder\": {\"text\": [[\"rhinopharyngitis\"]], \"start\": [[25]], \"entity_id\": [\"T11\"]}, \"Drug\": {\"text\": [[\"imidazoline derivative\"]], \"start\": [[91]], \"entity_id\": [\"T12\"]}, \"Route\": {\"text\": [[\"naphazoline\"]], \"start\": [[114]], \"entity_id\": [\"T13\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"due\"]], \"start\": [[40]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"Three diabetic cases\"]], \"start\": [[0]], \"entity_id\": [\"T3\"], \"Population\": {\"text\": [[\"Three\"]], \"start\": [[0]], \"entity_id\": [\"T7\"]}}, \"Effect\": {\"text\": [[\"acute dizziness\"]], \"start\": [[24]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"initial administration of voglibose\"]], \"start\": [[47]], \"entity_id\": [\"T6\"], \"Drug\": {\"text\": [[\"voglibose\"]], \"start\": [[73]], \"entity_id\": [\"T9\"]}, \"Disorder\": {\"text\": [[\"diabetic\"]], \"start\": [[6]], \"entity_id\": [\"T10\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"in\"]], \"start\": [[35]], \"entity_id\": [\"T5\"]}, \"Effect\": {\"text\": [[\"Fatal cold medication intoxication\"]], \"start\": [[0]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"cold medication\"]], \"start\": [[6]], \"entity_id\": [\"T7\"], \"Drug\": {\"text\": [[\"cold medication\"]], \"start\": [[6]], \"entity_id\": [\"T11\"]}}, \"Subject\": {\"text\": [[\"infant\"]], \"start\": [[41]], \"entity_id\": [\"T8\"], \"Age\": {\"text\": [[\"infant\"]], \"start\": [[41]], \"entity_id\": [\"T9\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[69]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"sodium warfarin\"]], \"start\": [[53]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"sodium warfarin\"]], \"start\": [[53]], \"entity_id\": [\"T6\"]}}, \"Effect\": {\"text\": [[\"necrotizing fasciitis\"]], \"start\": [[77]], \"entity_id\": [\"T5\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"taking\"]], \"start\": [[93]], \"entity_id\": [\"T10\"]}, \"Treatment\": {\"text\": [[\"dofetilide\"]], \"start\": [[100]], \"entity_id\": [\"T7\"], \"Drug\": {\"text\": [[\"dofetilide\"]], \"start\": [[100]], \"entity_id\": [\"T14\"]}, \"Disorder\": {\"text\": [[\"atrial fibrillation\"]], \"start\": [[115]], \"entity_id\": [\"T15\"]}}, \"Subject\": {\"text\": [[\"an elderly man\"]], \"start\": [[78]], \"entity_id\": [\"T8\"], \"Age\": {\"text\": [[\"elderly\"]], \"start\": [[81]], \"entity_id\": [\"T11\"]}, \"Gender\": {\"text\": [[\"man\"]], \"start\": [[89]], \"entity_id\": [\"T12\"]}}, \"Effect\": {\"text\": [[\"Marked QT prolongation and torsades de pointes secondary to acute ischemia\"]], \"start\": [[0]], \"entity_id\": [\"T9\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[38]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"Methylphenidate and dextroamphetamine\"]], \"start\": [[0]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"dextroamphetamine\"], [\"Methylphenidate\"]], \"start\": [[20], [0]], \"entity_id\": [\"T7\", \"T8\"]}}, \"Effect\": {\"text\": [[\"peripheral vasculopathy\"]], \"start\": [[46]], \"entity_id\": [\"T6\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"cause\"]], \"start\": [[41]], \"entity_id\": [\"T10\"]}, \"Effect\": {\"text\": [[\"severe hemodynamic deterioration\", \"systemic hypotension, pulmonary hypertension, and bronchoconstriction\"]], \"start\": [[47, 98]], \"entity_id\": [\"T9\"]}, \"Treatment\": {\"text\": [[\"The reversal of heparin by protamine\"]], \"start\": [[0]], \"entity_id\": [\"T12\"], \"Drug\": {\"text\": [[\"heparin\"], [\"protamine\"]], \"start\": [[16], [27]], \"entity_id\": [\"T16\", \"T17\"]}, \"Combination\": [{\"event_id\": \"E2\", \"event_type\": \"Combination\", \"Trigger\": {\"text\": [[\"reversal\"]], \"start\": [[4]], \"entity_id\": [\"T15\"]}, \"Drug\": {\"text\": [[\"heparin\"], [\"protamine\"]], \"start\": [[16], [27]], \"entity_id\": [\"T16\", \"T17\"]}}]}, \"Speculated\": {\"text\": [[\"may\"]], \"start\": [[37]], \"entity_id\": [\"T11\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"in\"]], \"start\": [[44]], \"entity_id\": [\"T6\"]}, \"Effect\": {\"text\": [[\"severe apnea\"]], \"start\": [[31]], \"entity_id\": [\"T3\"]}, \"Subject\": {\"text\": [[\"an infant\"]], \"start\": [[47]], \"entity_id\": [\"T4\"], \"Age\": {\"text\": [[\"infant\"]], \"start\": [[50]], \"entity_id\": [\"T7\"]}}, \"Treatment\": {\"text\": [[\"exposed to lamotrigine through breast-feeding\"]], \"start\": [[57]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"lamotrigine\"]], \"start\": [[68]], \"entity_id\": [\"T8\"]}, \"Route\": {\"text\": [[\"breast-feeding\"]], \"start\": [[88]], \"entity_id\": [\"T9\"]}}, \"Severity\": {\"text\": [[\"severe\"]], \"start\": [[31]], \"entity_id\": [\"T10\"], \"value\": \"Medium\"}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"following\"]], \"start\": [[21]], \"entity_id\": [\"T6\"]}, \"Effect\": {\"text\": [[\"Hemodynamic collapse\"]], \"start\": [[0]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"labetalol\"]], \"start\": [[31]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"labetalol\"]], \"start\": [[31]], \"entity_id\": [\"T7\"]}, \"Disorder\": {\"text\": [[\"preeclampsia\"]], \"start\": [[59]], \"entity_id\": [\"T8\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"developed\"]], \"start\": [[45]], \"entity_id\": [\"T10\"]}, \"Subject\": {\"text\": [[\"35-year old female\"]], \"start\": [[22]], \"entity_id\": [\"T9\"], \"Age\": {\"text\": [[\"35-year old\"]], \"start\": [[22]], \"entity_id\": [\"T13\"]}, \"Gender\": {\"text\": [[\"female\"]], \"start\": [[34]], \"entity_id\": [\"T14\"]}}, \"Effect\": {\"text\": [[\"type II diabetes mellitus with hyperosmolar hyperglycaemic coma and acute renal failure\"]], \"start\": [[65]], \"entity_id\": [\"T11\"]}, \"Treatment\": {\"text\": [[\"treatment with a SGA\"]], \"start\": [[163]], \"entity_id\": [\"T12\"], \"Drug\": {\"text\": [[\"SGA\"]], \"start\": [[180]], \"entity_id\": [\"T15\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"occurrence\"]], \"start\": [[14]], \"entity_id\": [\"T7\"]}, \"Treatment\": {\"text\": [[\"thrombolytic therapy with intravenous recombinant tissue-type plasminogen activator (t-PA)\"]], \"start\": [[92]], \"entity_id\": [\"T9\"], \"Route\": {\"text\": [[\"intravenous\"]], \"start\": [[118]], \"entity_id\": [\"T10\"]}, \"Drug\": {\"text\": [[\"recombinant tissue-type plasminogen activator\"]], \"start\": [[130]], \"entity_id\": [\"T11\"]}}, \"Effect\": {\"text\": [[\"renal failure due to cholesterol crystal embolization\"]], \"start\": [[28]], \"entity_id\": [\"T8\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Potential_therapeutic_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Potential_therapeutic_event\", \"Trigger\": {\"text\": [[\"resolved\"]], \"start\": [[11]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"three albuterol inhalations\"]], \"start\": [[46]], \"entity_id\": [\"T6\"], \"Disorder\": {\"text\": [[\"asthma\"]], \"start\": [[4]], \"entity_id\": [\"T7\"]}, \"Dosage\": {\"text\": [[\"three\"]], \"start\": [[46]], \"entity_id\": [\"T8\"]}, \"Drug\": {\"text\": [[\"albuterol\"]], \"start\": [[52]], \"entity_id\": [\"T9\"]}, \"Time_elapsed\": {\"text\": [[\"within 24 hours\"]], \"start\": [[20]], \"entity_id\": [\"T10\"]}, \"Route\": {\"text\": [[\"inhalations\"]], \"start\": [[62]], \"entity_id\": [\"T4\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"associated\"]], \"start\": [[33]], \"entity_id\": [\"T10\"]}, \"Treatment\": {\"text\": [[\"concomitant neuroleptic medication\", \"amantadine\"]], \"start\": [[125, 18]], \"entity_id\": [\"T9\"], \"Drug\": {\"text\": [[\"amantadine\"], [\"neuroleptic\"]], \"start\": [[18], [137]], \"entity_id\": [\"T15\", \"T16\"]}, \"Combination\": [{\"event_id\": \"E2\", \"event_type\": \"Combination\", \"Trigger\": {\"text\": [[\"concomitant\"]], \"start\": [[125]], \"entity_id\": [\"T17\"]}, \"Drug\": {\"text\": [[\"neuroleptic\"], [\"amantadine\"]], \"start\": [[137], [18]], \"entity_id\": [\"T16\", \"T15\"]}}]}, \"Effect\": {\"text\": [[\"psychotic decompensations\"]], \"start\": [[49]], \"entity_id\": [\"T11\"]}, \"Subject\": {\"text\": [[\"two schizophrenic patients\"]], \"start\": [[78]], \"entity_id\": [\"T12\"], \"Population\": {\"text\": [[\"two\"]], \"start\": [[78]], \"entity_id\": [\"T13\"]}, \"Disorder\": {\"text\": [[\"schizophrenic\"]], \"start\": [[82]], \"entity_id\": [\"T14\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"complication\"]], \"start\": [[89]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"disopyramide\"]], \"start\": [[105]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"disopyramide\"]], \"start\": [[105]], \"entity_id\": [\"T9\"]}}, \"Effect\": {\"text\": [[\"fasting hypoglycemia\"]], \"start\": [[30]], \"entity_id\": [\"T4\"]}, \"Speculated\": {\"text\": [[\"potentially\"]], \"start\": [[69]], \"entity_id\": [\"T7\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induced\"]], \"start\": [[80]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"captopril\"]], \"start\": [[70]], \"entity_id\": [\"T3\"], \"Drug\": {\"text\": [[\"captopril\"]], \"start\": [[70]], \"entity_id\": [\"T7\"]}}, \"Effect\": {\"text\": [[\"pemphigus\"]], \"start\": [[88]], \"entity_id\": [\"T5\"]}, \"Subject\": {\"text\": [[\"patient\"]], \"start\": [[57]], \"entity_id\": [\"T6\"]}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"to\"]], \"start\": [[41]], \"entity_id\": [\"T5\"]}, \"Effect\": {\"text\": [[\"hypersensitivity reaction\"]], \"start\": [[15]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"one formulation of cyclosporine\"]], \"start\": [[44]], \"entity_id\": [\"T4\"], \"Drug\": {\"text\": [[\"cyclosporine\"]], \"start\": [[63]], \"entity_id\": [\"T6\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"developed\"]], \"start\": [[4]], \"entity_id\": [\"T3\"]}, \"Effect\": {\"text\": [[\"urticarial rash\"]], \"start\": [[23]], \"entity_id\": [\"T4\"]}, \"Treatment\": {\"text\": [[\"Enoxaparin\"]], \"start\": [[84]], \"entity_id\": [\"T5\"], \"Time_elapsed\": {\"text\": [[\"3 weeks following\"]], \"start\": [[39]], \"entity_id\": [\"T6\"]}, \"Drug\": {\"text\": [[\"Enoxaparin\"]], \"start\": [[84]], \"entity_id\": [\"T7\"]}}, \"Severity\": {\"text\": [[\"severe\"]], \"start\": [[16]], \"entity_id\": [\"T8\"], \"value\": \"High\"}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"related to\"]], \"start\": [[33]], \"entity_id\": [\"T4\"]}, \"Effect\": {\"text\": [[\"Fatal toxic epidermal necrolysis\"]], \"start\": [[0]], \"entity_id\": [\"T3\"]}, \"Treatment\": {\"text\": [[\"lamotrigine administration\"]], \"start\": [[44]], \"entity_id\": [\"T5\"], \"Drug\": {\"text\": [[\"lamotrigine\"]], \"start\": [[44]], \"entity_id\": [\"T7\"]}}, \"Severity\": {\"text\": [[\"Fatal\"]], \"start\": [[0]], \"entity_id\": [\"T6\"], \"value\": \"Medium\"}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"associated\"]], \"start\": [[57]], \"entity_id\": [\"T7\"]}, \"Subject\": {\"text\": [[\"a case\"]], \"start\": [[23]], \"entity_id\": [\"T5\"]}, \"Effect\": {\"text\": [[\"serotonin syndrome (SS)\"]], \"start\": [[33]], \"entity_id\": [\"T6\"]}, \"Treatment\": {\"text\": [[\"mirtazapine monotherapy\"]], \"start\": [[73]], \"entity_id\": [\"T8\"], \"Drug\": {\"text\": [[\"mirtazapine\"]], \"start\": [[73]], \"entity_id\": [\"T9\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"induce\"]], \"start\": [[40]], \"entity_id\": [\"T10\"]}, \"Effect\": {\"text\": [[\"diabetes\"]], \"start\": [[47]], \"entity_id\": [\"T8\"]}, \"Treatment\": {\"text\": [[\"indapamide\"]], \"start\": [[25]], \"entity_id\": [\"T9\"], \"Drug\": {\"text\": [[\"indapamide\"]], \"start\": [[25]], \"entity_id\": [\"T14\"]}, \"Disorder\": {\"text\": [[\"essential hypertension\"]], \"start\": [[59]], \"entity_id\": [\"T15\"]}}, \"Subject\": {\"text\": [[\"essential hypertension patients\"]], \"start\": [[59]], \"entity_id\": [\"T11\"]}, \"Speculated\": {\"text\": [[\"may\"]], \"start\": [[36]], \"entity_id\": [\"T13\"], \"value\": true}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Potential_therapeutic_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Potential_therapeutic_event\", \"Trigger\": {\"text\": [[\"preventing\"]], \"start\": [[200]], \"entity_id\": [\"T15\"]}, \"Subject\": {\"text\": [[\"patients with nonmyeloid malignancies\"]], \"start\": [[120]], \"entity_id\": [\"T12\"], \"Disorder\": {\"text\": [[\"nonmyeloid malignancies\"]], \"start\": [[134]], \"entity_id\": [\"T17\"]}}, \"Treatment\": {\"text\": [[\"recombinant human interleukin-11 (rhIL-11, also known as oprelvekin [Neumega])\"]], \"start\": [[38]], \"entity_id\": [\"T11\"], \"Disorder\": {\"text\": [[\"postchemotherapy platelet nadirs of < or = 20,000/microL\"]], \"start\": [[211]], \"entity_id\": [\"T16\"]}, \"Drug\": {\"text\": [[\"recombinant human interleukin-11\"]], \"start\": [[38]], \"entity_id\": [\"T13\"]}}}" } ] } ]

[ { "events": [ { "event_id": "E1", "event_type": "Adverse_event", "event_data": "{\"event_id\": \"E1\", \"event_type\": \"Adverse_event\", \"Trigger\": {\"text\": [[\"developed\"]], \"start\": [[36]], \"entity_id\": [\"T7\"]}, \"Subject\": {\"text\": [[\"A patient with rheumatoid arthritis\"]], \"start\": [[0]], \"entity_id\": [\"T3\"]}, \"Effect\": {\"text\": [[\"acute intrahepatic cholestasis\"]], \"start\": [[49]], \"entity_id\": [\"T5\"]}, \"Treatment\": {\"text\": [[\"100 mg of sodium aurothiomalate\"]], \"start\": [[86]], \"entity_id\": [\"T8\"], \"Disorder\": {\"text\": [[\"rheumatoid arthritis\"]], \"start\": [[15]], \"entity_id\": [\"T4\"]}, \"Dosage\": {\"text\": [[\"100 mg\"]], \"start\": [[86]], \"entity_id\": [\"T10\"]}, \"Drug\": {\"text\": [[\"sodium aurothiomalate\"]], \"start\": [[96]], \"entity_id\": [\"T11\"]}}}" } ] } ]